Yunus Erdem

1. Comparing Outcomes of Spousal Kidney Transplants with Living-Related Donors in DSA-Positive Recipients: Is the Risk Increased in Husband-to-Wife Donation?Ozkara F., HABERAL G., YETER H. H., YILDIRIM T., ERDEM Y., YILMAZ Ş. R.NEPHRON, cilt.150, ss.156-166, 2026 (SCI-Expanded, Scopus)
2. Age and Cognitive Impairment in Dialysis Patients: A Cross-Sectional AnalysisYıldırım S., ERDUT A., Altunok M., YILDIRIM T., HELVACI Ö., ¸ankaya E., et al.Turkish Journal of Nephrology, cilt.35, sa.2, ss.104-110, 2026 (ESCI, Scopus, TRDizin)
3. Exaggerated axial osteoproliferation in patients with spondyloarthritis accompanying chronic kidney diseaseUzun G. S., APAYDIN ROLLAS A. E., HABERAL G., YETER H. H., AYAN G., ERDEM Y., et al.Clinical Rheumatology, 2026 (SCI-Expanded, Scopus)
4. Urinary Biomarker Profiles Define Divergent Pathways in Albuminuric and Non-Albuminuric Diabetic Kidney DiseaseKAYGUSUZ Y., Özbek D. A., ERDUT A., Abanoz R., Korkut M. G., ÖZDEDE M., et al.Kidney Diseases, cilt.12, sa.1, ss.330-345, 2026 (SCI-Expanded, Scopus)
5. Prevalence of Hypertension and Blood Pressure Control in Familial Mediterranean Fever PatientsKAVGACI G., YETER H. H., ÜZERK KİBAR M., YILDIRIM T., Peynircioglu B. B., YILMAZ Ş. R., et al.INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, cilt.2025, sa.1, 2025 (SCI-Expanded, Scopus)
6. Effect of post-transplant diabetes mellitus on cardiovascular events and mortality: a single‐center retrospective cohort studyÜNLÜTÜRK U., YILDIRIM T., Savaş M., Oğuz S. H., FIRLATAN B., YÜCE D., et al.Endocrine, cilt.85, sa.2, ss.695-703, 2024 (SCI-Expanded, Scopus)
7. Effect of medium cut-off membranes on Pentosidine and N-(carboxymethyl) lysine levels in uncontrolled diabetic hemodialysis patientsKoç N. S., YETER H. H., YILDIRIM T., ERDEM Y., Yılmaz R.Therapeutic Apheresis and Dialysis, cilt.28, sa.4, ss.591-598, 2024 (SCI-Expanded, Scopus)
8. How many blood pressure measurements should we take in the office?ÖZKAN G., ULUSOY Ş., Yilmaz R., DEĞER S. M., DERİCİ Ü., Arinsoy T., et al.JOURNAL OF CLINICAL HYPERTENSION, cilt.26, sa.6, ss.708-713, 2024 (SCI-Expanded, Scopus)
9. Chronic Kidney Disease Risk in Living Kidney Transplant Donors: A Long-Term Follow-Up StudyHABERAL G., YILDIRIM T., YILMAZ Ş. R., ALTUN B., AKI F. T., ERDEM Y., et al.Nephron, cilt.148, sa.3, ss.171-178, 2024 (SCI-Expanded, Scopus)
10. A comparative urinary proteomic and metabolomic analysis between renal aa amyloidosis and membranous nephropathy with clinicopathologic correlationsÖZBEK D. A., Koc S. C., Kucuk N. E. O., Kablan S., YET İ., ÜNER M., et al.JOURNAL OF PROTEOMICS, cilt.293, 2024 (SCI-Expanded, Scopus)
11. The Effect of Ambient Air Pollution on Office, Home, and 24-Hour Ambulatory Blood Pressure MeasurementsULUSOY Ş., Özkan G., Varol G., ERDEM Y., DERİCİ Ü., Yılmaz R., et al.American journal of hypertension, cilt.36, sa.8, ss.431-438, 2023 (SCI-Expanded, Scopus)
12. Assessment of Adherence to Immunosuppressive Treatment in Kidney Transplant Patients: A Descriptive StudyTECEN YÜCEL K., EKİNCİOĞLU A. B., YILDIRIM T., DEMİRKAN K., ERDEM Y.Turkish journal of nephrology (Online), cilt.32, sa.3, ss.241-248, 2023 (Scopus, TRDizin)
13. Comparison of lupus nephritis and non-lupus nephritides in patients with systemic lupus erythematosusDURAN E., BİLGİN E., KALYONCU U., ERTENLİ A. İ., YILDIRIM T., ARICI M., et al.Ulusal Romatoloji Dergisi, cilt.15, sa.1, ss.18-24, 2023 (Scopus, TRDizin)
14. Cytoplasmic WT1 in IgA nephropathy, an indicator of poor prognosis associated with mesangial/peri-mesangial C4dTAŞAR KAPAKLI G. E., ÜZERK KİBAR M., Dag O., Erdem Y., BAYDAR D., Saglam A.INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.55, sa.3, ss.661-669, 2023 (SCI-Expanded, Scopus)
15. Evaluation of drug interaction between cyclosporine and lercanidipine: a descriptive studyTecen-Yucel K., Bayraktar-Ekincioglu A., Ylldlrlm T., Demirkan K., ERDEM Y.European Journal of Hospital Pharmacy, 2023 (SCI-Expanded, Scopus)
16. Quality of life and physical activity level in patients with chronic kidney disease during COVID-19 pandemicFIRAT M., VARDAR YAĞLI N., SAĞLAM M., YILDIRIM T., ERDEM Y.PSYCHOLOGY HEALTH & MEDICINE, cilt.28, sa.3, ss.640-647, 2023 (SCI-Expanded, SSCI, Scopus)
17. A standard hemodialysis prescription to prevent osmotic demyelination in hyponatremic patients requiring dialysisKOÇ N. S., YILDIRIM T., GİRGİN S., ÖNAL C., TAHILLIOĞLU Y., Yilmaz R., et al.THERAPEUTIC APHERESIS AND DIALYSIS, cilt.26, sa.6, ss.1182-1186, 2022 (SCI-Expanded, Scopus)
18. Trends of primary glomerular disease in Turkey: TSN-GOLD registry reportGul C. B., Kucuk M., Ozturk S., Demir E., EREN N., Sumnu A., et al.INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.54, sa.9, ss.2285-2294, 2022 (SCI-Expanded, Scopus)
19. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experienceSARIYILDIZ E., YILDIRIM T., Taghiyeva A., Bilgin E., ARICI M., Saglam E. A., et al.LUPUS, cilt.31, ss.1147-1156, 2022 (SCI-Expanded, Scopus)
20. Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional StudyBALABAN H. Y., ASLAN A. T., AKDOĞAN KITTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.33, sa.7, ss.615-624, 2022 (SCI-Expanded, Scopus, TRDizin)
21. Bacterial Bloodstream Infection in Renal Transplant Recipients: 15 years of experience in a university hospitalÇALIK BAŞARAN N., ÖZYAVUZ ALP Ş., ASLAN A. T., PAHSAYEV T., YILDIRIM T., YILMAZ Ş. R., et al.ERCIYES MEDICAL JOURNAL, 2022 (ESCI, TRDizin)
22. Effects of Interdialytic Weight Gain and Salt Intake on Serum Vascular Endothelial Growth Factor-C (VEGF-C) Levels in Hemodialysis PatientsTurkmen E., Altindal M., YILDIRIM T., Yilmaz R., ARICI M., ERDEM Y., et al.TURKISH JOURNAL OF NEPHROLOGY, cilt.31, sa.2, ss.171-176, 2022 (ESCI, Scopus, TRDizin)
23. Renal effects of long-term lithium therapy, revisitedYazici M. K., Eroglu E. O., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E., Agaoglu E., KARAHAN S., et al.HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, cilt.37, sa.2, 2022 (SCI-Expanded, Scopus)
24. Impact of the kidney transplantation on renalase and blood pressure levels in renal transplant donors and recipientsYilmaz R., YILDIRIM T., Abudalal A., ERDEM Y.NEFROLOGIA, cilt.42, sa.2, ss.171-176, 2022 (SCI-Expanded, Scopus)
25. Does Blood Pressure Variability Affect Hypertension Development in Prehypertensive Patients?ÖZKAN G., ULUSOY Ş., ARICI M., DERİCİ Ü., Akpolat T., ŞENGÜL Ş., et al.AMERICAN JOURNAL OF HYPERTENSION, cilt.35, sa.1, ss.73-78, 2022 (SCI-Expanded, Scopus)
26. Evaluation of renal fibrosis in various causes of glomerulonephritis by MR elastography: a clinicopathologic comparative analysisGÜVEN A. T., İDİLMAN İ. S., Cebrayilov C., ÖNAL C., ÜZERK KİBAR M., Saglam A., et al.ABDOMINAL RADIOLOGY, cilt.47, sa.1, ss.288-296, 2022 (SCI-Expanded, Scopus)
27. The effect of hypertension and antihypertensive therapies on the course of COVID-19 infection: Turkish national health system dataÖZKAN G., ULUSOY Ş., ERDEM Y., ALTUN B., Yilmaz R., Ata N., et al.CLINICAL AND EXPERIMENTAL HYPERTENSION, cilt.44, ss.502-506, 2022 (SCI-Expanded, Scopus)
28. Early recognition of chronic rejection in a face allotransplant patient with alopeciaAKDOĞAN N., ERSOY EVANS S., GÖKÖZ Ö., ERDEM Y., Nasir S.JOURNAL OF CUTANEOUS PATHOLOGY, cilt.48, sa.10, ss.1286-1297, 2021 (SCI-Expanded, Scopus)
29. What Has Changed with the Implementation of National Cadaveric Kidney Allocation Policy in Turkey?YAVUZ O., YILDIRIM T., Yilmaz R., CANKURTARAN M., ERDEM Y.TURKISH JOURNAL OF NEPHROLOGY, cilt.30, sa.3, ss.199-204, 2021 (ESCI, Scopus, TRDizin)
30. Efficacy and Safety of Switching to Azathioprine for Mycophenolate-Induced Diarrhea in Renal Transplant RecipientsSEKMEK S., YILDIRIM T., KOÇ N. S., ÖNAL C., Jabrayilov J., Yilmaz R., et al.TRANSPLANTATION PROCEEDINGS, cilt.53, sa.6, ss.1951-1956, 2021 (SCI-Expanded, Scopus)
31. Underlying Causes and Risk Factors of Chronic Renal Allograft Dysfunction Among Renal Transplant RecipientsGÜVEN G., YILMAZ Ş. R., YILDIRIM T., AKI F. T., ERDEM Y.Acta Medica, cilt.52, sa.2, ss.152-161, 2021 (TRDizin)
32. MEAN PLATELET VOLUME IN FAMILIAL MEDITERRANEAN FEVER RELATED AMYLOIDOSIS AND COMPARISON WITH COMMON PRIMARY GLOMERULAR DISEASESYILDIRIM T., Kutahya B., İŞ F., ERDEVİR M., ÜZERK KİBAR M., KOÇ N. S., et al.NEPHROLOGY DIALYSIS TRANSPLANTATION, cilt.36, 2021 (SCI-Expanded, Scopus)
33. EFFICACY AND SAFETY OF SWITCHING TO AZATHIOPRINE FOR MYCOPHENOLATE INDUCED DIARRHEA IN RENAL TRANSPLANT RECIPIENTSSEKMEK S., YILDIRIM T., KOÇ N. S., ÖNAL C., Jabrayilov J., YILMAZ Ş. R., et al.NEPHROLOGY DIALYSIS TRANSPLANTATION, cilt.36, 2021 (SCI-Expanded, Scopus)
34. A New Approach to Tertiary Hyperparathyroidism: Percutaneous Embolization: Two Case ReportsKOÇ N. S., Yilmaz R., YILDIRIM T., Eldem G., PEYNİRCİOĞLU B., ERDEM Y.TRANSPLANTATION PROCEEDINGS, cilt.53, sa.3, ss.1010-1013, 2021 (SCI-Expanded, Scopus)
35. Petroselinum crispum, a commonly consumed food, affects sirolimus level in a renal transplant recipient: a case reportKurtaran M., KOÇ N. S., AKSUN M. S., YILDIRIM T., YILMAZ Ş. R., ERDEM Y.THERAPEUTIC ADVANCES IN DRUG SAFETY, cilt.12, 2021 (SCI-Expanded, Scopus)
36. Early Post-transplant Recurrence of Amyloidosis in a Patient with Familial Mediterranean FeverÖZBEK D. A., KOÇ N. S., Saglam A., YILDIRIM T., YILMAZ Ş. R., ERDEM Y.TURKISH JOURNAL OF NEPHROLOGY, cilt.30, sa.2, ss.179-182, 2021 (ESCI, Scopus, TRDizin)
37. Renal Lymphangiomatosis Mimicking Polycystic Kidney Disease In An Adult, A Case Report and Literature ReviewKOÇ N. S., YILMAZ Ş. R., KARÇAALTINCABA M., YILDIRIM T., ERDEM Y.IRANIAN JOURNAL OF KIDNEY DISEASES, cilt.15, sa.1, ss.61-63, 2021 (SCI-Expanded, Scopus)
38. Mean platelet volume in familial Mediterranean fever related AA amyloidosis and comparison with common primary glomerular diseasesYILDIRIM T., Kutahya B., İŞ F., ERDEVİR M., ÜZERK KİBAR M., KOÇ N. S., et al.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.5, ss.2364-2368, 2021 (SCI-Expanded, Scopus, TRDizin)
39. Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant RecipientsTecen-Yucel K., Bayraktar-Ekincioglu A., YILDIRIM T., YILMAZ Ş. R., Demirkan K., ERDEM Y.JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, cilt.26, sa.10, ss.1291-1296, 2020 (SCI-Expanded, Scopus)
40. Which out-of-office measurement technique should be used for diagnosing hypertension in prehypertensives?ULUSOY Ş., ÖZKAN G., ARICI M., DERİCİ Ü., Akpolat T., ŞENGÜL Ş., et al.JOURNAL OF HUMAN HYPERTENSION, cilt.34, sa.8, ss.586-592, 2020 (SCI-Expanded, Scopus)
41. The Weekend Effect in Chronic Hemodialysis Patients, a Single Center ExperienceYILDIRIM T., ŞENER Y. Z., BÖLEK E. Ç., Yilmaz R., ARICI M., ALTUN B., et al.IRANIAN JOURNAL OF KIDNEY DISEASES, cilt.14, sa.3, ss.219-223, 2020 (SCI-Expanded, Scopus)
42. Ultrastructural evaluation of urine alkalinization versus hydration on colistin-induced nephrotoxicityKorucu B., Unal I., Pekcan M., İNKAYA A. Ç., Yeter H. H., ÇETİNKAYA M. A., et al.Human and Experimental Toxicology, cilt.38, sa.12, ss.1366-1377, 2019 (SCI-Expanded, Scopus)
43. Down-regulation of miRNA 145 and up-regulation of miRNA 4516 may be associated with primary hypertensionÖZKAN G., ULUSOY Ş., Geyik E., ERDEM Y.JOURNAL OF CLINICAL HYPERTENSION, cilt.21, sa.11, ss.1724-1731, 2019 (SCI-Expanded, Scopus)
44. 2019 Turkish Hypertension Consensus ReportAydogdu S., Guler K., BAYRAM F., ALTUN B., DERİCİ Ü., ABACI A., et al.TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.47, sa.6, ss.535-546, 2019 (ESCI, Scopus, TRDizin)
45. Role of Local Renin Angiotensin System Activation on Blood Pressure and Residual Renal Function in Peritoneal Dialysis PatientsYILDIRIM T., Yilmaz R., Azak A., Altindal M., TÜRKMEN E., ARICI M., et al.TURKISH JOURNAL OF NEPHROLOGY, cilt.28, sa.1, ss.17-23, 2019 (ESCI, Scopus, TRDizin)
46. Data on prevalence of obesity and waist circumference in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factorsUral D., Kilickap M., GÖKSÜLÜK H., Karaaslan D., Kayikcioglu M., ÖZER N., et al.TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.46, sa.7, ss.577-590, 2018 (ESCI, Scopus, TRDizin)
47. Canakinumab treatment in renal transplant recipients with familial Mediterranean feverYILDIRIM T., Yilmaz R., ÜZERK KİBAR M., ERDEM Y.JOURNAL OF NEPHROLOGY, cilt.31, sa.3, ss.453-455, 2018 (SCI-Expanded, Scopus)
48. Home sphygmomanometers can help in the control of blood pressure: a nationwide field surveyAkpolat T., ARICI M., ŞENGÜL Ş., DERİCİ Ü., ULUSOY Ş., ERTÜRK Ş., et al.HYPERTENSION RESEARCH, cilt.41, sa.6, ss.460-468, 2018 (SCI-Expanded, Scopus)
49. Monoclonal gammopathy of renal significance presenting as monotypic plasma cell interstitial nephritis in two patients with Sjogren's syndromeSaglam A., Balaban S., YILDIRIM T., ERDEM Y., ÜNER A., BÜYÜKAŞIK Y.VIRCHOWS ARCHIV, cilt.472, sa.5, ss.865-869, 2018 (SCI-Expanded, Scopus)
50. Do physicians measure patients' blood pressure, and are those measurements reliable?ULUSOY Ş., ÖZKAN G., GÜVERCİN B., Sokmen Y., ERDEM Y.JOURNAL OF HUMAN HYPERTENSION, cilt.32, sa.3, ss.203-211, 2018 (SCI-Expanded, Scopus)
51. Implementation of clinical pharmacy practices in nephrology unitTecen K., ÜZERK KİBAR M., KAVGACI G., Bayraktar-Ekincioglu A., Demirkan K., YILDIRIM T., et al.INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, cilt.40, sa.1, ss.281, 2018 (SCI-Expanded, Scopus)
52. The effect of intermittent fasting on blood pressure variability in patients with newly diagnosed hypertension or prehypertensionERDEM Y., ÖZKAN G., ULUSOY Ş., ARICI M., DERİCİ Ü., ŞENGÜL Ş., et al.JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, cilt.12, sa.1, ss.42-49, 2018 (SCI-Expanded, Scopus)
53. EFFECT OF NEW ONSET DIABETES AFTER RENAL TRANSPLANTATION ON CARDIOVASCULAR DISEASE AND MORTALITYYILDIRIM T., SAVAŞ E. M., ÜNLÜTÜRK U., EYÜPOĞLU N. D., Selimova C., Yilmaz R., et al.TRANSPLANT INTERNATIONAL, cilt.30, ss.266, 2017 (SCI-Expanded, Scopus)
54. Dietary Sources of High Sodium Intake in Turkey: SALTURK IIERDEM Y., Akpolat T., DERİCİ Ü., ŞENGÜL Ş., ERTÜRK Ş., ULUSOY Ş., et al.NUTRIENTS, cilt.9, sa.9, 2017 (SCI-Expanded, Scopus)
55. IN VIVO EVALUATION OF PROTECTIVE EFFECT OF HYDRATION WITH SODIUM CHLORIDE VERSUS URINE ALKALINISATION ON COLISTIN INDUCED NEPHROTOXICITY IN RATSKorucu B., Unal I., Pekcan M., ÇETİNKAYA M. A., KAYMAZ F. F., İNKAYA A. Ç., et al.NEPHROLOGY DIALYSIS TRANSPLANTATION, cilt.32, 2017 (SCI-Expanded, Scopus)
56. A novel marker in pregnant with preeclampsia: renalaseYilmaz Z. V., Akkas E., YILDIRIM T., Yilmaz R., ERDEM Y.JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, cilt.30, sa.7, ss.808-813, 2017 (SCI-Expanded, Scopus)
57. Turkish doctors' cohort: healthy despite low screeningÜNAL S., Tanriover M., Ascioglu S., Demirkazik A., Ertenli I., ESKİOGLU E., et al.POSTGRADUATE MEDICINE, cilt.129, sa.3, ss.393-398, 2017 (SCI-Expanded, Scopus)
58. Kidney transplantation for end-stage renal disease secondary to familial Mediterranean feverAltindal M., TÜRKMEN E., YILDIRIM T., Yilmaz R., AKI F. T., ARICI M., et al.CLINICAL TRANSPLANTATION, cilt.30, sa.7, ss.787-790, 2016 (SCI-Expanded, Scopus)
59. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012ŞENGÜL Ş., Akpolat T., ERDEM Y., DERİCİ Ü., ARICI M., Sindel S., et al.JOURNAL OF HYPERTENSION, cilt.34, sa.6, ss.1208-1217, 2016 (SCI-Expanded, Scopus)
60. Evaluation of Renal Biopsies for BK Virus Nephropathy in Non-Renal Transplant Immunosuppressed PatientsMerhametsiz O., YILDIRIM T., Gok Oguz E., Ercan Z., Yayar O., Yilmaz R., et al.TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.25, sa.2, ss.162-167, 2016 (ESCI, Scopus, TRDizin)

All 88 on AVESİS →

1. Inadequate diagnostic investigations and low treatment rates in CKD anemia: an inertia that can only change with long-term follow-upKurak C. d. K., Karlik S., HAYRAN K. M., HABERAL G., ERDUT A., YETER H. H., et al.61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)
2. IMPACT OF HYPERTENSION ON OUTCOMES IN PATIENTS WITH MEMBRANOUS NEPHROPATHYŞENER Y. Z., Jabrayilov J., ÇELEBİ G., HABERAL G., ERDUT A., Ayhan A. S., et al.33rd European Meeting on Hypertension and Cardiovascular Renal Protection (ESH), Berlin, Almanya, 31 Mayıs - 03 Haziran 2024, (Özet Bildiri)
3. Membranous nephropathy has higher all-cause mortality rate in comparison to focal segmental glomerulosclerosis and IgA nephropathy: a long-term studyZiya Y. S., Jabrayi'lov J., ÇELEBİ G., HABERAL G., ERDUT A., YETER H. H., et al.61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)
4. The effects of characteristics associated with dialysis on cognitive functions in patients with chronic kidney diseaseYildirim S., Altinok M., ERDUT A., YILDIRIM T., HELVACI Ö., DERİCİ Ü., et al.61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)
5. TRENDS OF PRIMARY GLOMERULAR DISEASE IN TURKEY FROM 2009 TO 2017: A REGIONAL REGISTRY REPORT FROM TSN-GOLD WORKING GROUPGul C. B., Kucuk M., Ozturk S., Demir E., Eren N., Sumnu A., et al.57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.740, (Özet Bildiri)
6. THE WEEKEND EFFECT IN CHRONIC HEMODIALYSIS PATIENTS: A SINGLE CENTER EXPERIENCEYILDIRIM T., ŞENER Y. Z., BÖLEK E. Ç., Yilmaz R., ARICI M., ALTUN B., et al.56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest, Macaristan, 13 - 16 Haziran 2019, cilt.34, ss.573, (Özet Bildiri)
7. DO PHYSICIANS MEASURE PATIENTS' BLOOD PRESSURE, AND ARE THOSE MEASUREMENTS RELIABLE?Sukru U., ÖZKAN G., GÜVERCİN B., Sokmen Y., ERDEM Y.27th Scientific Meeting of the International-Society-of-Hypertension, Beijing, Çin, 20 - 23 Eylül 2018, cilt.36, (Özet Bildiri)
8. Bacterial blood stream infections in renal transplantation recipients:16 years experience with 702 patients in a tertiary care university hospitalCalık Basaran N., Alp S., YILDIRIM T., AKI F. T., SANCAK B., YILMAZ Ş. R., et al.European Congress of Clinical Microbiology and Infectious Diseases, 21 - 24 Nisan 2018, (Özet Bildiri)
9. Denizlerdeki dalga ile gelen böbrek yetmezliğipASHAYEV T., ÇALIK BAŞARAN N., ÖZIŞIK L., DURUSU TANRIÖVER M., ARICI M., ERDEM Y.19. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Türkiye, 11 - 15 Ekim 2017, (Özet Bildiri)
10. Implementation of clinical pharmacy practices in nephrology unitTECEN YÜCEL K., ÜZERK KİBAR M., KAVGACI G., Ekincioğlu A., DEMİRKAN S. K., YILDIRIM T., et al.46th symposium on clinical pharmacy Heidelberg, Germany, 9 - 11 Ekim 2017, (Özet Bildiri)
11. IN VIVO EVALUATION OF PROTECTIVE EFFECT OF HYDRATION WITH SODIUM CHLORIDE VERSUS URINE ALKALINISATION ON COLISTIN INDUCED NEPHROTOXICITY IN RATSKORUCU B., ÜNAL I., PEKCAN M., ÇETİNKAYA M. A., KAYMAZ F. F., İNKAYA A. Ç., et al.54th ERA-EDTA CONGRESS, Madrid, İspanya, 3 - 06 Haziran 2017, (Özet Bildiri)
12. Urinary Type III Procollagen Is Associated With Chronic AllograftDysfunction and Predicts Graft SurvivalYILMAZ Ş. R., YILDIRIM T., BAYDAR D., ALTUN B., ERDEM Y.2017 American Transplant Congress, 29 Nisan - 03 Mayıs 2017, (Özet Bildiri)
13. RENAL ALLOGREFT BİYOPSİ PATOLOJİLERİNİN GREFT FONKSİYONU İLE İLİŞKİSİTONYALI Ş., HABERAL H. B., YILDIRIM T., YILMAZ Ş. R., ARICI M., ERDEM Y., et al.6.Ulusal Transplantasyon İmmünolojisi ve Genetiği Kongresi, Antalya, Türkiye, 6 - 09 Nisan 2017, (Özet Bildiri)
14. RENAL TRANSPLANTASYON HASTALARININ BÖBREK TÜMÖRÜ: PRETRANSPLANTASYON POSTTRASNPLANTASYON BÖBREK TÜMÖRÜ GELİŞTİRENLER VE TÜMÖRLÜ BÖBREK NAKLEDİLENLERTONYALI Ş., HABERAL H. B., DOĞAN H. S., ERDEM Y., BİLEN C. Y., AKI F. T.6.Ulusal Transplantasyon İmmünolojisi ve Genetiği Kongresi, Antalya, Türkiye, 6 - 09 Nisan 2017, (Özet Bildiri)
15. RENAL TRANSPLANTASYON ÖNCESİ HASTA DEĞERLENDİRMESİ: LUMİNEX CROSS-MATCH’İN YERİTONYALI Ş., YILDIRIM T., HABERAL H. B., YAZICI M. S., YILMAZ Ş. R., ERDEM Y., et al.6.Ulusal Transplantasyon İmmünolojisi ve Genetiği Kongresi, Türkiye, 6 - 09 Nisan 2017, (Özet Bildiri)
16. DİRENÇLİ MEMBRANÖZ GLOMERÜLONEFRİTTE RİTUKSİMAB KULLANIMI TEK MERKEZ DENEYİMİŞENER Y. Z., YILDIRIM T., YILMAZ Ş. R., ARICI M., ALTUN B., ERDEM Y.33. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Türkiye, 19 - 23 Ekim 2016
17. SP799EFFECT OF RENAL TRANSPLANTATION ON RENALASE LEVELS IN DONORS AND RECIPIENTSABUDALAL A., YILDIRIM T., YILMAZ Ş. R., ARICI M., ALTUN B., ERDEM Y.52 rd ERA-EDTA CONGRESS LONDON 2015, 28 - 31 Mayıs 2015
18. FP831PROGNOSTIC ROLE OF SERUM PROCOLLAGEN LEVELS ON GRAFT SURVIVAL IN RENAL TRANSPLANT RECIPIENTSYILDIRIM T., YILMAZ Ş. R., BAYDAR D., ARICI M., ALTUN B., ERDEM Y.52nd ERA-EDTA CONGRESS LONDON 2015, 28 - 31 Mayıs 2015
19. PROGNOSTIC ROLE OF SERUM PROCOLLAGEN LEVELS ON GRAFT SURVIVAL IN RENALTRANSPLANT RECIPIENTSYILDIRIM T., Yilmaz R., BAYDAR D., ARICI M., ALTUN B., ERDEM Y.52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation, London, Kanada, 28 - 31 Mayıs 2015, cilt.30, (Özet Bildiri)
20. EFFECT OF RENAL TRANSPLANTATION ON RENALASE LEVELS IN DONORS AND RECIPIENTSAbudalal A., YILDIRIM T., Yilmaz R., ARICI M., ALTUN B., ERDEM Y.52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation, London, Kanada, 28 - 31 Mayıs 2015, cilt.30, (Özet Bildiri)
21. EFFECT OF VITAMIN D REPLACEMENT ON ENDOTHELIAL FUNCTIONS IN RENAL TRANSPLANT RECIPIENTSYILDIRIM T., Yilmaz R., TÜRKMEN E., Altindal M., ARICI M., ALTUN B., et al.51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA), Amsterdam, Hollanda, 31 Mayıs - 03 Haziran 2014, cilt.29, ss.322, (Özet Bildiri)
22. LOCAL RENIN ANGIOTENSIN SYSTEM ACTIVATION IN PREECLAMPSIAYilmaz Z., YILDIRIM T., Yilmaz R., Aybal-Kutlugun A., ALTUN B., Kucukozkan T., et al.50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, İstanbul, Türkiye, 18 - 21 Mayıs 2013, cilt.28, ss.90-91, (Özet Bildiri)
23. ENDOTHELIAL DYSFUNCTION IN RENAL TRANSPLANT RECIPIENTS: ROLE OF VITAMIN D AND FIBROBLAST GROWTH FACTOR-23YILDIRIM T., Yilmaz R., Altindal M., TÜRKMEN E., ARICI M., ALTUN B., et al.50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, İstanbul, Türkiye, 18 - 21 Mayıs 2013, cilt.28, ss.275, (Özet Bildiri)
24. URINARY PROCOLLAGEN PREDICTS DEGREE OF RENAL FIBROSIS IN RENAL TRANSPLANT RECIPIENTSYILDIRIM T., Yilmaz R., TÜRKMEN E., Abudalal A., Altindal M., Ertoy-Baydar D., et al.50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, İstanbul, Türkiye, 18 - 21 Mayıs 2013, cilt.28, ss.503-504, (Özet Bildiri)
25. BLOOD PRESSURE AND RESIDUAL RENAL FUNCTION IN PERITONEAL DIALYSIS: ROLE OF LOCAL RENIN ANGIOTENSIN SYSTEM ACTIVATIONYILDIRIM T., Yilmaz R., Azak A., Altindal M., TÜRKMEN E., ARICI M., et al.50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, İstanbul, Türkiye, 18 - 21 Mayıs 2013, cilt.28, ss.223-224, (Özet Bildiri)
26. RELATIONSHIP BETWEEN BLOOD PRESSURE VALUES, BLOOD PRESSURE VARIABILITY AND ENDOTHELIAL FUNCTIONS IN RENAL TRANSPLANT RECIPIENTSOzkayar N., ALTUN B., YILDIRIM T., Yilmaz R., Dede F., HAYRAN K. M., et al.50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, İstanbul, Türkiye, 18 - 21 Mayıs 2013, cilt.28, ss.85-86, (Özet Bildiri)
27. Sleep duration, coronary artery calcification and inflammation in maintenance hemodialysis patientsKirkpantur A., Yilmaz R., Emmungil H., HAZIROLAN T., ARICI M., ALTUN B., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.331, (Özet Bildiri)
28. Proton pump inhibitor use and bone mineral densitometry in maintenance hemodialysis patientsKirkpantur A., Yilmaz R., AKOĞLU H., ARICI M., ALTUN B., ERDEM Y., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.174-175, (Özet Bildiri)
29. Ultrasonographic lower limb enthesitis score predicts coronary artery calcification in maintenance hemodialysis patientsKirkpantur A., Yilmaz R., Kerimoglu U., HAZIROLAN T., ARICI M., ALTUN B., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.340, (Özet Bildiri)
30. Persistent elevation of inflammation marker C-reactive protein is associated with atherosclerosis and left ventricular hypertrophy in chronic hemodialysis patients: 2 year follow-up studyYilmaz R., Kirkpantur A., Deniz A., Ciftci O., ALTUN B., ARICI M., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.312, (Özet Bildiri)
31. The utility of the Doppler ultrasound parameter, resistive index, in renal transplant histopathologyKirkpantur A., Yilmaz R., BAYDAR D., Aki T., ARICI M., ALTUN B., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.272-273, (Özet Bildiri)
32. The role of inflammatory activity and atherosclerosis on thrombosed arterio-venous fistula for hemodialysis accessYilmaz R., Kirkpantur A., ALTUN B., AKOĞLU H., Aki T., ERDEM Y., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.159, (Özet Bildiri)
33. The association between coronary artery calcification, arteriovenous fistula thrombosis and bone mineral density in maintenance hemodialysis patients: Is serum fetuin-A level the missing link?Kirkpantur A., ALTUN B., Yilmaz R., HAZIROLAN T., Aki T., ARICI M., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.327, (Özet Bildiri)
34. Serum matrix metalloproteinase 2, 9 and tissue inhibitor of metalloproteinase 1 levels in mild hypertensive patients: Effect of blood pressure treatmentOnal I. K., Altun B., Yilmaz R., Kirkpantur A., Arici M., Oz S. G., et al.43rd ERA-EDTA Congress, Glasgow, Birleşik Krallık, 15 - 18 Temmuz 2006, cilt.21, ss.303, (Özet Bildiri)
35. Impact of cytokine gene polymorphisms on cardiovascular risk in renal transplant recipients: One-year follow-up studyYilmaz R., Altun B., Kirkpantur A., Sahiner L., Arici M., Erdem Y., et al.43rd ERA-EDTA Congress, Glasgow, Birleşik Krallık, 15 - 18 Temmuz 2006, cilt.21, ss.516, (Özet Bildiri)
36. Serum lipid profile and arteriovenous fistula thrombosis risk: A retrospective study on reverse epidemiologyKirkpantur A., Yilmaz R., Aki T., Bakkaloglu M., Altun B., Arici M., et al.43rd ERA-EDTA Congress, Glasgow, Birleşik Krallık, 15 - 18 Temmuz 2006, cilt.21, ss.467, (Özet Bildiri)
37. Cystatin C is a novel marker for estimating GFR: Is it purely indicator in renal transplant recipients?Yilmaz R., Kirkpantur A., Akoglu H., Arici M., Altun B., Erdem Y., et al.43rd ERA-EDTA Congress, Glasgow, Birleşik Krallık, 15 - 18 Temmuz 2006, cilt.21, ss.305, (Özet Bildiri)
38. IS THERE AN ASSOCİATİON BETWEEN HYPOALBUMİNEMİA OF VARİOUS ETİOLOGİES ON CELLULAR ADHESİON MOLECULESSERKAN K., ARICI M., ALTUN B., ÇALIK BAŞARAN N., ERDEM Y., YASAVUL Ü., et al.XXXIX. CONGRESS OF THE EUROPEAN RENAL ASSOCİATİON, EUROPEAN DİALYSİS AND TRANSPLANT ASSOCİATİON, KOPENHAG, Danimarka, 14 - 17 Temmuz 2002, cilt.17, (Özet Bildiri)
39. Hepatitis E Virus Epidemiology and Genotype Analysis Among Special Risk Groups in Turkey, 16. Ulusal Hepato Gastroenteroloji Kongresi, 17-23 Ekim 2019-Girne, KKTC.ASLAN A. T., BALABAN H. Y., AYAR Ş. N., AKDOĞAN KİTTANA F. N., ALP A., Vahabov C., et al.
40. Bacterial bloodstream infections in renal transplantation recipients: 16 years experience wit 702 patient in a tertiary care university hospitalÇALIK BAŞARAN N., ÖZYAVUZ ALP Ş., YILDIRIM t., AKİ t., SANCAK B., YİLMAZ r., et al.
41. EFFECT OF NEW ONSET DIABETES AFTER RENAL TRANSPLANTATION ON CARDIOVASCULAR DISEASE AND MORTALITYYILDIRIM T., SAVAŞ E. M., ÜNLÜTÜRK U., EYÜPOĞLU N. D., SELİMOVA C., YILMAZ Ş. R., et al.
42. Can urine alkalinisation be a treatment option on colistin induced nephrotoxicity: an ultrastructural and histochemical study on ratsKORUCU B., ÜNAL I., PEKCAN M., ÇETİNKAYA M. A., KAYMAZ F. F., HAYRAN K. M., et al.
43. TERSİYER HİPERPARATİROİDİDECERRAHİ TEDAVİ Mİ? CİNACALCET Mİ?HACETTEPE ÜNİVERSİTESİ DENEYİMİSAVAŞ E. M., ÜNLÜTÜRK U., YILDIRIM T., EYÜPOĞLU N. D., SELİMOVA C., YILMAZ Ş. R., et al.
44. Renal transplantasyon sonrası gelişen diabetes mellitusun kardiyovasküler hastalık gelişimi ve sağkalım üzerine etkileriYILDIRIM T., ÜNLÜTÜRK U., YILMAZ Ş. R., ERDEM Y., BAYRAKTAR M.
45. Renal transplant alıcılarında görülen CMV enfeksiyonlarının serolojik ve moleküler tanısıÇİÇEK M., BORAL B., ŞENER Y. Z., AMAN A., İNKAYA A. Ç., ERDEM Y., et al.